How Eli Lilly’s new GLP‑1 pill stacks up against Wegovy and other weight‑loss drugs

Scientific American Scientific American

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss.

The drug, called Foundayo, resulted in an average of 27 pounds lost in 72 weeks

Read full article at Scientific American →